News | August 14, 2009

Lantheus Seeks New Mo-99 Supplies, Solutions to Isotope Crisis

August 14, 2009 - Lantheus Medical Imaging will continue to allocate its Mo-99 supply to serve as many people as possible, said the company today in response to the statement issued by AECL regarding the extended shutdown of the NRU reactor Aug. 12.

Lantheus is collaborating with its supply partners and key customers to address the ongoing global isotope shortage of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m) used in its TechneLite generators, as a result of the prolonged NRU reactor shutdown in Canada and the current shutdown of the High Flux Reactor (HFR) in the Netherlands.

In an effort to actively explore options to obtain additional Mo-99, the company announced new Mo-99 supply agreements with NTP Radioisotopes (Pty) Ltd., a subsidiary of the Nuclear Energy Corp. of South Africa (NECSA), the National Institute for Radioelements (IRE), Belgium, and the Australian Nuclear Science and Technology Organisation (ANSTO) as a supplier for low-enriched uranium (LEU) Mo-99 in the North America, respectively, to manufacture and supply us with an ongoing volume of Mo-99.  These agreements demonstrate our continued commitment to investing in a supply chain diversification strategy to address the limited and fragile global Mo-99 supply chain.  Additionally, the company has significantly increased production of thallium 201 in our cyclotrons on site which are operating at full capacity to meet the demand for this alternate cardiac imaging agent during the Mo-99 shortage.

Lantheus recently endorsed the American Medical Isotopes Production Act sponsored by Representatives Edward J. Markey (D-Mass.), chairman of the House Energy and Commerce Committee Subcommittee on Energy and the Environment, and Fred Upton (R-Mich.), the ranking member of the subcommittee, which seeks to ensure that a reliable supply of critical medical isotopes is produced in the United States as soon as possible.

For more information: www.lantheus.com

Related Content

Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...